Biosimilar Pricing and Competition: How Political Visibility Shapes Biologic Pricing after Loss of Exclusivity Introduction Biologics have reshaped the treatment landscape across a broad Read More »
Communicate the value How an interactive gene therapy budget impact model produced greater internal understanding and facilitated communication with external stakeholders Read More
Optimize your evidence plan How synthesizing multiple perspectives has enabled the refinement of the market access strategy for four novel cell therapies Read More
